This HTML5 document contains 146 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n10http://dx.doi.org/10.1017/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38491903
rdf:type
wikibase:Item
schema:description
scientific article published on 20 May 2015 wetenschappelijk artikel مقالة علمية نشرت في 20 مايو 2015 artikulong pang-agham vědecký článek наукова стаття, опублікована в травні 2015 2015年论文 teaduslik artikkel scientific article published on 20 May 2015 artículo científico scienca artikolo vedecký článok 2015年論文 научна статия 2015年论文 artigo científico বৈজ্ঞানিক নিবন্ধ tudományos cikk 2015年论文 2015年論文 bilimsel makale научни чланак articolo scientifico article científic tieteellinen artikkeli scientific article published on 20 May 2015 บทความทางวิทยาศาสตร์ 2015年论文 bài báo khoa học vitskapeleg artikkel 2015年論文 επιστημονικό άρθρο artigo científico article scientific מאמר מדעי научная статья wissenschaftlicher Artikel 2015年论文 სამეცნიერო სტატია artikull shkencor 2015년 논문 научни чланак 2015年論文 2015年の論文 articol științific artykuł naukowy artikel ilmiah vetenskaplig artikel vitenskapelig artikkel article scientifique videnskabelig artikel 2015年论文 naučni članak artigo científico 2015年論文 2015 nî lūn-bûn artículu científicu espublizáu en 2015 мақолаи илмӣ
p:P577
wds:Q38491903-8455DB0F-C13B-4D64-B84F-66C1162A119C
wdt:P577
2015-05-20T00:00:00Z
p:P2860
wds:Q38491903-2A4A7D4E-94B8-4A08-9F4B-C3C2357EA647 wds:Q38491903-2E909BDC-EE50-436C-BE77-7507CFFFCF2E wds:Q38491903-43FE44D3-35C2-459E-9BEC-9B92BCD36B99 wds:Q38491903-46C32B2A-77B0-42E2-8DE4-76B879854193 wds:Q38491903-4CA5E260-6E88-444F-86C6-12FD54D6AE78 wds:Q38491903-59BA22AD-1FD5-4E8C-B646-FE3D42D47BDF wds:Q38491903-61A28313-1A60-4968-857A-95D6D85F0BAF wds:Q38491903-27D0AB67-8681-41E6-B58C-407E61BDFE47 wds:Q38491903-28BDFD4A-FA3E-4917-B7FB-B87769D120E9 wds:Q38491903-C69149D3-3943-43DB-B8F9-19C2AE94199C wds:Q38491903-EA3A8AC3-8DAA-4E81-8A99-D517075C3A03 wds:Q38491903-F421A95A-B2A2-47A8-ABA9-41C3041905D9 wds:Q38491903-F970635D-1BC8-4591-81C8-D1A0539A6D0F wds:Q38491903-FB3B9E0E-9361-4788-9ADB-1062129E6CF2 wds:Q38491903-90B969AF-30AC-4033-8D00-661C914C78DE wds:Q38491903-9816A9A3-D03A-42E3-A733-2A9C930933D8 wds:Q38491903-ABFB2175-F3D4-402C-B78B-C0C26C3A2F95 wds:Q38491903-B571257A-87A2-4018-A8E9-692F0AAD53BB wds:Q38491903-6C96F71F-ED5F-46DC-8E2D-8F7DB18E72B0 wds:Q38491903-6E3F5BB7-30F4-44C3-9EE8-061977444815 wds:Q38491903-7AF41C05-0594-49BD-99A3-DEC915283A50 wds:Q38491903-7E18BAA6-9889-4E90-B8AB-8541015C485F wds:Q38491903-84869C3B-A6BD-4854-B06D-B8FB4E576378 wds:Q38491903-8FC30293-5296-4CA3-A9BD-1FCA5B119228
wdt:P2860
wd:Q34409161 wd:Q84434183 wd:Q35008952 wd:Q63352440 wd:Q73502679 wd:Q28262641 wd:Q69841897 wd:Q42237011 wd:Q36200940 wd:Q70933682 wd:Q34318170 wd:Q36885833 wd:Q33233913 wd:Q37996539 wd:Q57151319 wd:Q28278620 wd:Q44389803 wd:Q24815557 wd:Q38024937 wd:Q34378699 wd:Q34660529 wd:Q30053056 wd:Q28274196 wd:Q46637283
p:P2093
wds:Q38491903-B23F7BAE-18D4-4201-9A4C-07A69527120B wds:Q38491903-72FD96A5-C7B0-4F3B-8284-0DB08C4E58F4 wds:Q38491903-E7A56AC9-3496-413C-9467-3667FBB6EADC
wdt:P2093
Amel Arnaout Moeber Mahzari Mark S Freedman
rdfs:label
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management
skos:prefLabel
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management
schema:name
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management
p:P1476
wds:Q38491903-0349989D-1CFF-4C46-A4D2-69A6D96F3520
wdt:P1476
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management
p:P304
wds:Q38491903-E257697F-B938-4DA5-91E8-7643AEBFA25D
wdt:P304
284-291
p:P31
wds:Q38491903-B17A4C59-713F-4A08-A22E-7FEB79F67AB5 wds:Q38491903-bd515e1e-7551-4944-8377-230f8e1c31e2
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q38491903-5C8FF751-C8F0-4A4B-90A8-B7991EE38DE1
wdt:P921
wd:Q8277
p:P698
wds:Q38491903-8FC3B6CE-A1F1-4F51-8C66-D86F612A49BA
wdtn:P698
n11:25990097
wdt:P698
25990097
p:P1433
wds:Q38491903-28E37F5D-8C21-41D2-8DB3-EA6BCB10D025
wdt:P1433
wd:Q5030246
p:P433
wds:Q38491903-BEB2B623-BF16-402A-91AA-AF9DE07C5C9F
p:P478
wds:Q38491903-A30A49B7-A1A5-4A62-9B18-40759A733645
wdt:P433
5
wdt:P478
42
p:P356
wds:Q38491903-1B5E5E67-E955-458C-B3A9-4699A847182C
wdtn:P356
n10:CJN.2015.48
wdt:P356
10.1017/CJN.2015.48